PROGNOSIS

The prognosis is very poor in HRS if treatment is not rapidly provided. Mortality of untreated type I disease, for example, is up to 80% in 2 weeks. Patients with type 2 have a slightly better prognosis, with a median survival of months rather than weeks. Nonetheless, their survival is still shorter than that of a cirrhotic patient with ascites but without renal dysfunction.